疏肝健脾消积汤结合西医治疗原发性肝癌临床疗效探讨

To study effect of Shuganjianpi negatively Tang treatment of primary liver cancer clinical efficacy and safety studies

目的:对疏肝健脾消积汤治疗原发性肝癌的临床有效性与安全性进行观察研究。方法:2013年2月-2014年2月本院接诊的98例中晚期原发性肝癌患者,分为观察组和对照组,对照组予以西医药物治疗,观察组在予以西医药治疗的基础上加服疏肝健脾消积汤,比较两组患者临床疗效。结果:观察组总改善率为89.8%,明显高于对照组73.3%,比较有显著性差异(P<0.05),有统计学意义。结论:疏肝健脾消积汤结合西医治疗原发性肝癌,疗效显著,值得推广。

Objective： Shuganjianpi negatively Tang treatment of primary liver cancer clinical efficacy and safety studies were observed. Methods： 98 cases of patients with advanced primary liver cancer in Our hospital from February 2013 to February 2014, Divided into two groups and the control group and the control group were given Western medicine treatment, observation group to be treated on the basis of Western medicine plus service Shuganjianpi negatively soup, the clinical efficacy of two groups were compared.Results： The total improvement rate was 89.8%, significantly higher than 73.3%, there was a significant difference （P 〈0.05）, there are statistically significant. Conclusion： Shuganjianpi negatively soup combined with Western medicine treatment of primary liver cancer, a significant effect, it is worth promoting.